• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology practitioners from India.

作者信息

Gupta Latika, Misra Durga Prasanna, Agarwal Vishwesh, Balan Suma, Agarwal Vikas

机构信息

Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, UP, India.

Mahatma Gandhi Mission's Medical College, Navi Mumbai, Maharashtra, India.

出版信息

Ann Rheum Dis. 2021 Jan;80(1):e1. doi: 10.1136/annrheumdis-2020-217509. Epub 2020 Apr 16.

DOI:10.1136/annrheumdis-2020-217509
PMID:32299795
Abstract
摘要

相似文献

1
Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology practitioners from India.2019冠状病毒病大流行时期的风湿性疾病管理：印度风湿病从业者的观点
Ann Rheum Dis. 2021 Jan;80(1):e1. doi: 10.1136/annrheumdis-2020-217509. Epub 2020 Apr 16.
2
The conundrum of COVID-19 treatment targets: the close correlation with rheumatology. Response to: 'Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology pracitioners from India' by Gupta and 'Antirheumatic agents in covid-19: is IL-6 the right target?' by Capeechi .2019冠状病毒病治疗靶点的难题：与风湿病学的密切关联。回应：古普塔所著的《2019冠状病毒病大流行期间的风湿病管理：印度风湿病从业者的观点》以及卡佩奇所著的《2019冠状病毒病中的抗风湿药物：白细胞介素-6是正确的靶点吗？》
Ann Rheum Dis. 2021 Jan;80(1):e3. doi: 10.1136/annrheumdis-2020-217545. Epub 2020 Apr 27.
3
Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases.COVID-19 相关住院风险因素在自身免疫性炎症性风湿病患者中的分析。
Ann Rheum Dis. 2020 Nov;79(11):1393-1399. doi: 10.1136/annrheumdis-2020-217984. Epub 2020 Aug 7.
4
Trajectories of COVID-19 information in the Annals of the Rheumatic Diseases: the first months of the pandemic.《风湿病学年鉴》中新冠疫情相关信息的轨迹：疫情爆发的头几个月
Ann Rheum Dis. 2021 Jan;80(1):26-30. doi: 10.1136/annrheumdis-2020-219217. Epub 2020 Oct 14.
5
Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic, including recommendations for COVID-19 vaccination.德国风湿病学会关于在SARS-CoV-2/COVID-19大流行背景下照顾炎性风湿性疾病患者的最新建议，包括COVID-19疫苗接种建议。
Z Rheumatol. 2021 Dec;80(Suppl 2):33-48. doi: 10.1007/s00393-021-01055-7. Epub 2021 Sep 7.
6
COVID-19 and the practice of rheumatology in Africa: big changes to services from the shockwave of a pandemic.2019冠状病毒病与非洲的风湿病诊疗实践：大流行冲击波给服务带来的巨大变化
Ann Rheum Dis. 2021 Jun;80(6):e100. doi: 10.1136/annrheumdis-2020-218273. Epub 2020 Jul 1.
7
Clinical outcomes of Covid-19 in patients with rheumatic diseases and the effects of the pandemic on rheumatology outpatient care: A single-centre experience from Turkey.土耳其单中心研究：风湿性疾病患者感染 COVID-19 的临床转归及大流行对风湿科门诊护理的影响。
Int J Clin Pract. 2021 Sep;75(9):e14442. doi: 10.1111/ijcp.14442. Epub 2021 Jun 27.
8
[SARS-CoV-2 & rheumatic disease : Consequences of the SARS-CoV-2 pandemic for patients with inflammatory rheumatic diseases. A comparison of the recommendations for action of rheumatological societies and risk assessment of different antirheumatic treatments].[严重急性呼吸综合征冠状病毒2与风湿性疾病：严重急性呼吸综合征冠状病毒2大流行对炎性风湿性疾病患者的影响。风湿学会行动建议与不同抗风湿治疗风险评估的比较]
Z Rheumatol. 2020 Sep;79(7):686-691. doi: 10.1007/s00393-020-00878-0. Epub 2020 Aug 26.
9
[Prospective monitoring of a university rheumatology outpatient clinic throughout the first wave of the COVID-19 pandemic : What lessons can be learned?].[在新冠疫情第一波期间对大学风湿病门诊进行前瞻性监测：能吸取哪些教训？]
Z Rheumatol. 2021 Jun;80(5):408-417. doi: 10.1007/s00393-020-00935-8. Epub 2020 Nov 30.
10
Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic.德国风湿病学会（DGRh eV）关于SARS-CoV-2/COVID-19大流行期间炎性风湿性疾病患者管理的初步建议。
Ann Rheum Dis. 2020 Jun;79(6):840-842. doi: 10.1136/annrheumdis-2020-217628. Epub 2020 Apr 28.

引用本文的文献

1
Survey-based observational research: Quality, relevance and optimal use in the post-COVID-19 era.基于调查的观察性研究：后新冠疫情时代的质量、相关性及最佳应用
J R Coll Physicians Edinb. 2022 Sep;52(3):199-200. doi: 10.1177/14782715221125611.
2
COVID-19 and inflammatory bowel disease crosstalk: From emerging association to clinical proposal.COVID-19 与炎症性肠病的相互作用：从新出现的关联到临床建议。
J Med Virol. 2022 Dec;94(12):5640-5652. doi: 10.1002/jmv.28067. Epub 2022 Aug 24.
3
COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis.
COVID-19 患者皮肌炎的结局：基于登记的队列分析。
Semin Arthritis Rheum. 2022 Oct;56:152034. doi: 10.1016/j.semarthrit.2022.152034. Epub 2022 May 28.
4
Clinical outcomes of COVID-19 patients with rheumatic diseases: a retrospective cohort study and synthesis analysis in Wuhan, China.COVID-19 患者合并风湿病的临床结局：一项中国武汉的回顾性队列研究和综合分析。
Clin Rheumatol. 2022 Jun;41(6):1899-1910. doi: 10.1007/s10067-022-06086-2. Epub 2022 Feb 16.
5
The impact of the ongoing COVID-19 pandemic on the management of rheumatic disease: a national clinician-based survey.正在进行的 COVID-19 大流行对风湿性疾病管理的影响：一项基于全国临床医生的调查。
Rheumatol Int. 2022 Apr;42(4):601-608. doi: 10.1007/s00296-022-05102-7. Epub 2022 Feb 14.
6
COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging Association, Therapeutic Options and Challenges.COVID-19 与类风湿关节炎的相互作用：新兴关联、治疗选择与挑战。
Cells. 2021 Nov 24;10(12):3291. doi: 10.3390/cells10123291.
7
Managing ANCA-associated vasculitis during the COVID-19 pandemic: results from an online survey.管理 COVID-19 大流行期间的抗中性粒细胞胞质抗体相关性血管炎：一项在线调查的结果。
Rheumatol Int. 2021 Nov;41(11):1941-1947. doi: 10.1007/s00296-021-04975-4. Epub 2021 Aug 24.
8
COVID-19 and Myositis: What We Know So Far.COVID-19 与肌炎：目前我们所了解的。
Curr Rheumatol Rep. 2021 Jul 3;23(8):63. doi: 10.1007/s11926-021-01023-9.
9
Managing patients using telerheumatology: Lessons from a pandemic.利用远程风湿病学管理患者：大流行带来的经验教训。
Best Pract Res Clin Rheumatol. 2021 Mar;35(1):101662. doi: 10.1016/j.berh.2021.101662. Epub 2021 Jan 30.
10
COVID-19: What Do Rheumatologists Need to Know?COVID-19：风湿病学家需要了解什么？
Curr Rheumatol Rep. 2021 Jan 5;23(1):5. doi: 10.1007/s11926-020-00971-y.